Key facts
- It has raised $860K; the latest was Early Stage VC in Sep 2025.
- Notable investors include Imec.istart, Draper University, RUG Ventures, Triade Investment, Future Tech Ventures — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for Sencilia
- ·The full record, as it builds
Funding rounds
No funding rounds for Sencilia are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sencilia
Developer of intravenous line infusion monitoring services intended to improve patient safety in neonatal and pediatric intensive care. The company specializes in offering flow management automation technology, diagnosing respiratory disorders, and providing flow sensors and underwater sensing systems, enabling the healthcare, robotics, water, and energy industries to improve the accuracy of fluid balance and mitigate nurse workload.
- Sector
- Information Technology
- HQ
- Groningen, Netherlands
- Founded
- 2021
- Employees
- 8
- Website
- sencilia.nl/
- Ownership
- Privately Held (backing)
Sencilia doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sencilia shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sencilia in its N-PORT filings yet. We sweep new filings monthly.